Maravai LifeSciences Holdings, Inc. (MRVI) stock
MRVINasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 5, 2026Score 7/30170% above fair value
$7.40−0.14 (-1.86%)
Close on Nov 16, 2026Market cap $1.92BP/E –Yield –
Maravai LifeSciences EV/EBITDA
EV/EBITDA is enterprise value divided by EBITDA over the trailing twelve months.
Maravai LifeSciences's EV/EBITDA was 14.9× on Jan 31, 2024, against 5.7× a year earlier. Over the last 2 years it ranged from 5.6× to 367.8×, with a median of 9.2×.
EV/EBITDA at the end of each year
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| 2024 | Jan 31, 2024 | 14.9× | −1.4 |
| 2023 | Dec 29, 2023 | 16.3× | +10.7 |
| 2022 | Dec 30, 2022 | 5.6× | −362.2 |
| 2021 | Jan 29, 2021 | 367.8× | +71.9 |
| 2020 | Dec 31, 2020 | 295.9× | – |
See a number that looks wrong?